-
CONIDIA CONIPHY launched a new service to track fungicide resistance
CONIDIA CONIPHY has added a new service to its portfolio to detect and monitor fungicide resistance of downy mildew disease in grapevine. After 5 years of research, development efforts and investment in new DNA/gene sequencing technologies, CONIDIA CONIPHY launched a new innovative method/tool: Fungi RESIST. Fungi RESIST can alert and measure resistance against fungicides used in the field. Downy mildew of grapevines is a devastating disease, and the use of fungicides is important to control and protect grapevines. An effective fungicide-resistance surveillance system is essential to detect fungicide resistance quickly before it spreads, helping preserve fungicide effectiveness and crop protection. In the context of global agricultural awareness of fungicide…
-
Tentamus North America Spotlights Expert Legionella Testing Services to Address Critical Public Health Risks
As the risk of Legionnaires‘ disease remains a critical public health concern, Tentamus North America is reinforcing its commitment to facility safety by highlighting its expert Legionella testing services for industries across the continent. The company is providing advanced, reliable testing solutions designed to help facility owners and managers proactively identify and mitigate Legionella contamination in building water systems. The critical importance of proactive Legionella testing is underscored by the bacteria’s prevalence in engineered water systems such as cooling towers, hot and cold water plumbing, spas, and fountains. Exposure to contaminated aerosols from these systems can lead to Legionnaires‘ disease, a severe form of pneumonia. Tentamus North America is uniquely positioned to support organizations in mitigating this…
-
Accelerating clinical development in Vienna
Turning breakthrough science into effective therapies requires more than innovation — it demands the right expertise, infrastructure, and seamless execution. This complexity is addressed by ClinXTrials – a powerhouse alliance based in Vienna. Gouya Insights, VelaLabs – a Tentamus company -, and ABF Pharmaceutical Services offer a one-stop solution to accelerate development and de-risk clinical translation. In the competitive world of biotechnology, companies face complex challenges in translating discoveries into successful clinical programs. With the right guidance, biotech companies can avoid unnecessary delays in preclinical development and move confidently toward clinical success. ClinXTrials unites deep expertise in clinical development, bioanalytic, and trial logistics to provide an integrated, end-to-end solution. Under…
-
Accelerator für klinischen Entwicklung in Wien
Bahnbrechende wissenschaftliche Erkenntnisse in wirksame Therapien zu überführen, erfordert mehr als nur Innovation – es bedarf der richtigen Expertise, Infrastruktur und reibungsloser Durchführung. Diese Komplexität wird bei ClinXTrials adressiert. Gouya Insights, VelaLabs – a Tentamus company – und ABF Pharmaceutical Services, drei innovative Unternehmen aus Wien, bieten gemeinsam eine integrierte Lösung an, um Entwicklungsprozesse zu beschleunigen und Risiken beim Übergang in die klinische Phase zu minimieren. In der wettbewerbsintensiven Biotechnologiebranche stehen Unternehmen vor der Herausforderung, wissenschaftliche Entdeckungen in erfolgreiche klinische Programme zu überführen. Mit der richtigen Unterstützung können Biotech-Firmen unnötige Verzögerungen in der präklinischen Phase vermeiden und bestärkt in Richtung klinischen Erfolg voranschreiten. ClinXTrials vereint umfassende Expertise in der klinischen…
-
The Oldenburg site of Tentamus Pharma & Med Deutschland GmbH celebrates its 30th anniversary this year
Since its founding in August 1995 as Dr. Kolkmann & Partner GmbH, the company has developed into an established player in the field of pharmaceutical analytics and drug research. Over the course of three decades, the site has undergone an impressive transformation. In 2008, the company was renamed Diapharm Analytics GmbH before being integrated into the internationally operating Tentamus Group in November 2018 – a significant step towards global networking and interdisciplinary collaboration. Since joining the Tentamus Group, the site has been operating under the name Tentamus Pharma & Med Deutschland GmbH and is now an integral part of the international network of over 90 laboratories and service facilities worldwide.…
-
30 Jahre pharmazeutische Kompetenz in Oldenburg – Tentamus Pharma & Med Deutschland feiert Jubiläum
Der Standort Oldenburg der Tentamus Pharma & Med Deutschland GmbH feiert in diesem Jahr sein 30-jähriges Bestehen. Seit der Gründung im August 1995 als Dr. Kolkmann & Partner GmbH hat sich das Unternehmen zu einer etablierten Größe im Bereich pharmazeutischer Analytik und Arzneimittelforschung entwickelt. Im Laufe der drei Jahrzehnte durchlief der Standort eine beeindruckende Entwicklung. 2008 firmierte das Unternehmen als Diapharm Analytics GmbH, bevor es im November 2018 in die international tätige Tentamus Group integriert wurde – ein bedeutender Schritt in Richtung globaler Vernetzung und interdisziplinärer Zusammenarbeit. Seit der Eingliederung in die Tentamus Group trägt der Standort den Namen Tentamus Pharma & Med Deutschland GmbH und ist heute ein fester…
-
Record Year for Minerva
Minerva Scientific – A Tentamus Company is a Food and Feed testing laboratory established in 2001, offering a wide range of ISO 17025 accredited tests ideal for due diligence-based surveillance testing, pertinent to UK and EU legislative requirements. Notably, our team at Minerva Scientific are the leading experts in Honey testing in the UK. In 2024, we experienced over a 30% increase in demand for our testing services — helping more businesses stay compliant and ensuring consumers receive the highest quality products. Here’s how we maintain exceptional service standards, even as demand for our testing services continues to grow: 1. Investment in Instrumentation The NUT01 test — used for the…
-
New in our portfolio: Headspace-SPME GC-MS
We now offer a new analytical method, Headspace SPME (solid phase microextraction), which is suitable for routine aroma analysis as well as for special analytical questions! Do you remember our article from last summer, in which we introduced you to our new Headspace SPME GC-MS? Back then, it was just an announcement of things to come, but after a lot of time spent on instrument testing and optimization, we are delighted to announce that our instrument is ready for use and approved for qualitative and quantitative analysis. With a few exceptions, e.g. odorous substances with high boiling points that do not easily transfer into the gaseous phase, solid-phase microextraction is…
-
Wir nehmen Abschied von Karsten Ott – ein geschätzter Geschäftsführer, Kollege und Mensch
Karsten Ott war über drei Jahrzehnte eine tragende Säule unseres Unternehmens. Seit seinem Eintritt in die bilacon im Jahr 1992 prägte er maßgeblich die Entwicklung und das Wachstum des Labors. Er leitete bis 2018 mit außerordentlicher Expertise die Abteilung für Instrumentelle Analytik, bevor er die Verantwortung für den Standort Berlin übernahm. Im Jahr 2022 wurde er in die Geschäftsführung berufen. Seit Mitte 2024 führte er das Unternehmen gemeinsam mit Frank Barsch. Die beiden ergänzten sich in ihrer Führungskompetenz und standen für Stabilität, Integrität und fachliche Exzellenz. Nach dem Tod von Karsten Ott wird Frank Barsch die Geschäftsführung der bilacon künftig alleinverantwortlich weiterführen. Karsten Ott war nicht nur für sein fundiertes…
-
EU to Limit PFAS in Food Packaging by 2026: What You Need to Know
New EU Regulation 2025/40 (PPWR) sets strict limits on PFAS in food packaging from August 2026, aiming to reduce environmental and health risks. The European Union has adopted Regulation 2025/40, introducing strict limits on PFAS (per- and polyfluoroalkyl substances) in food packaging and reduces single-use plastic in fresh produce and food services, pushing for more recyclable and reusable solutions. The goal is to minimize exposure to harmful substances and reduce environmental impact. PFAS are synthetic chemicals known for their persistence in the environment and potential health risks. From August 12, 2026, packaging materials that exceed specific concentration limits of PFAS will no longer be allowed on the EU market. In…
